This is crummy news. But keep in mind most MS meds have good safety profiles and that MS itself can be devastating. Keep researching, researchers. - D
BREAKING: Drugmakers Biogen Inc. and AbbVie Inc. said Friday they are pulling their new multiple-sclerosis treatment Zinbryta from all global markets after several European patients suffered serious inflammatory brain disorders.
Story in the Wall Street Journal
https://www.wsj.com/articles/biogen-...ket-1520007411
BREAKING: Drugmakers Biogen Inc. and AbbVie Inc. said Friday they are pulling their new multiple-sclerosis treatment Zinbryta from all global markets after several European patients suffered serious inflammatory brain disorders.
Story in the Wall Street Journal
https://www.wsj.com/articles/biogen-...ket-1520007411